#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous T-cell lymphoma refractory Acute myeloid leukaemia (in remission) Langerhans' cell histiocytosis KBG syndrome Precursor T-lymphoblastic lymphoma/leukaemia recurrent Cutaneous T-cell lymphoma Infantile apnoea Crigler-Najjar syndrome Gastrointestinal neuroendocrine tumour Wolfram syndrome Neurodegenerative disorder CDKL5 deficiency disorder T-cell lymphoma Immunodeficiency common variable Hyperinsulinaemic hypoglycaemia More trials…

    Learn about Rare Diseases

    Gaucher’s disease type III – Basic Information Primary hyperoxaluria – Trials in Disease Waldenstrom’s macroglobulinaemia recurrent – Trials in Disease Glomerulonephritis membranoproliferative – Treatment Hairy cell leukaemia – Life with Disease Familial amyotrophic lateral sclerosis – Treatment Atypical teratoid/rhabdoid tumour of CNS – Diagnostics Kearns-Sayre syndrome – Trials in Disease Primary hyperoxaluria IgA nephropathy – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    MORPHINE GRNA1599 Fondaparinux Sodium Fluvastatin Sodium Astegolimab Crgd-Zw800-1 Mitazalimab Lansoprazole Mifamurtide Natalizumab Dydrogesterone Rivaroxaban BROLUCIZUMAB Bi-1808 ACETYLCARNITINE HYDROCHLORIDE Oxitriptan Zetomipzomib Mps-103 Ibrutinib Sabirnetug More therapies…

    Learn about Your Condition

    Arrhythmia Neurofibrosarcoma Hepato-lenticular degeneration Inflammatory bowel disease Procedural headache Propionic acidaemia Cytomegalovirus infection Cushing's syndrome Haemofiltration Milk allergy Retinal neovascularisation Primary hypercholesterolaemia Dry eye Abdominal infection Testicular germ cell cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

C3 glomerulopathy

  • Effectiveness and Safety of Pegcetacoplan in Patients with C3 Glomerulopathy or Primary Immune Complex Membranoproliferative Glomerulonephritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glomerulonephritis membranoproliferative
    Investigated Drugs:
    • Pegcetacoplan
    France Germany Italy Spain

  • Study on Long-Term Effects of Iptacopan in Patients with C3 Glomerulopathy or Idiopathic Immune-Complex Membranoproliferative Glomerulonephritis

    Recruiting

    3 1 1
    Investigated Diseases:
    • C3 glomerulopathy
    Investigated Drugs:
    • Iptacopan Hydrochloride
    • Iptacopan
    Czechia France Germany Greece Italy The Netherlands +1

  • Study on the Effectiveness and Safety of Pegcetacoplan for Patients with C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • C3 glomerulopathy
    • Glomerulonephritis membranoproliferative
    Investigated Drugs:
    • Pegcetacoplan
    Austria Germany Italy The Netherlands

  • Study on the Safety and Effectiveness of Pegcetacoplan for Patients with Post-Transplant Recurrence of C3 Glomerulopathy or Immune Complex Membranoproliferative Nephritis

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • C3 glomerulopathy
    • Glomerulonephritis membranoproliferative
    Investigated Drugs:
    • Pegcetacoplan
    Austria Italy The Netherlands

  • Study on the Effectiveness and Safety of Iptacopan for Patients with Complement 3 Glomerulopathy

    Not recruiting

    3 1
    Investigated Drugs:
    • Iptacopan Hydrochloride
    • Iptacopan
    France Germany Greece Italy The Netherlands Slovakia +1

  • Study Comparing Aliskiren and Enalapril for Patients with C3 Glomerulopathy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • C3 glomerulopathy
    Investigated Drugs:
    • Aliskiren
    • Enalapril Maleate
    Sweden
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!